A Phase I, Open-Label Study Evaluating The Pharmacokinetics of Components of S-1 Patients With Impaired Hepatic Function.

Trial Profile

A Phase I, Open-Label Study Evaluating The Pharmacokinetics of Components of S-1 Patients With Impaired Hepatic Function.

Completed
Phase of Trial: Phase I

Latest Information Update: 11 Jun 2014

At a glance

  • Drugs Gimeracil/oteracil/tegafur (Primary)
  • Indications Solid tumours
  • Focus Pharmacokinetics
  • Sponsors Taiho Pharmaceutical
  • Most Recent Events

    • 11 Aug 2009 Actual end date (Mar 2009) added as reported by ClinicalTrials.gov.
    • 11 Aug 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
    • 14 Feb 2008 The expected completion date for this trial is now 1 Jul 2008 as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top